Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, Mullol J, Greos LS, Bosso JV, Laidlaw TM, Cervin AU, Maspero JF, Hopkins C, Olze H, Canonica GW, Paggiaro P, Cho SH, Fokkens WJ, Fujieda S, Zhang M, Lu X, Fan C, Draikiwicz S, Kamat SA, Khan A, Pirozzi G, Patel N, Graham NMH, Ruddy M, Staudinger H, Weinreich D, Stahl N, Yancopoulos GD, Mannent LP. Bachert C, et al. Among authors: laidlaw tm. Lancet. 2019 Nov 2;394(10209):1638-1650. doi: 10.1016/S0140-6736(19)31881-1. Epub 2019 Sep 19. Lancet. 2019. PMID: 31543428 Clinical Trial.
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
Mullol J, Laidlaw TM, Bachert C, Mannent LP, Canonica GW, Han JK, Maspero JF, Picado C, Daizadeh N, Ortiz B, Li Y, Ruddy M, Laws E, Amin N. Mullol J, et al. Among authors: laidlaw tm. Allergy. 2022 Apr;77(4):1231-1244. doi: 10.1111/all.15067. Epub 2021 Oct 1. Allergy. 2022. PMID: 34459002 Free PMC article.
Biologics in chronic rhinosinusitis with nasal polyposis.
Laidlaw TM, Buchheit KM. Laidlaw TM, et al. Ann Allergy Asthma Immunol. 2020 Apr;124(4):326-332. doi: 10.1016/j.anai.2019.12.001. Epub 2019 Dec 9. Ann Allergy Asthma Immunol. 2020. PMID: 31830587 Free PMC article. Review.
Chronic Rhinosinusitis with Nasal Polyps and Asthma.
Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP. Laidlaw TM, et al. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1133-1141. doi: 10.1016/j.jaip.2020.09.063. Epub 2020 Oct 13. J Allergy Clin Immunol Pract. 2021. PMID: 33065369 Free article.
Adult chronic rhinosinusitis.
Bachert C, Marple B, Schlosser RJ, Hopkins C, Schleimer RP, Lambrecht BN, Bröker BM, Laidlaw T, Song WJ. Bachert C, et al. Nat Rev Dis Primers. 2020 Oct 29;6(1):86. doi: 10.1038/s41572-020-00218-1. Nat Rev Dis Primers. 2020. PMID: 33122665 Review.
The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps.
Bachert C, Desrosiers MY, Hellings PW, Laidlaw TM. Bachert C, et al. Among authors: laidlaw tm. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1099-1106. doi: 10.1016/j.jaip.2020.11.017. Epub 2020 Nov 20. J Allergy Clin Immunol Pract. 2021. PMID: 33227522
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma.
Laidlaw TM, Bachert C, Amin N, Desrosiers M, Hellings PW, Mullol J, Maspero JF, Gevaert P, Zhang M, Mao X, Khan AH, Kamat S, Patel N, Graham NMH, Ruddy M, Staudinger H, Mannent LP. Laidlaw TM, et al. Ann Allergy Asthma Immunol. 2021 May;126(5):584-592.e1. doi: 10.1016/j.anai.2021.01.012. Epub 2021 Jan 16. Ann Allergy Asthma Immunol. 2021. PMID: 33465455 Free article. Clinical Trial.
165 results